TEQI:NYE-T. Rowe Price Equity Income ETF (USD)

ETF | Others |

Last Closing

USD 42.2905

Change

0.00 (0.00)%

Market Cap

USD 0.25B

Volume

6.35K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund normally invests at least 80% of its assets in common stocks listed in the United States, with an emphasis on large-capitalization stocks that have a strong track record of paying dividends or that are believed to be undervalued (or futures that have similar economic characteristics). It typically employs a value approach in selecting investments. The fund's in-house research team seeks companies that appear to be undervalued by various measures and may be temporarily out of favor but have good prospects for capital appreciation and dividend growth.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

ETFs Containing TEQI

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 15.77% 69% C- 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.77% 69% C- 69% C-
Trailing 12 Months  
Capital Gain 29.77% 69% C- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.77% 69% C- 68% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.09% 78% C+ 58% F
Dividend Return 7.91% 81% B- 56% F
Total Return 1.82% 66% D+ 42% F
Risk Return Profile  
Volatility (Standard Deviation) 12.46% 35% F 72% C
Risk Adjusted Return 63.50% 76% C+ 79% B-
Market Capitalization 0.25B 75% C 39% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.